المراجع

1.Lip GY, Fauchier L, Freedman SB et al. (2016) Atrial Fibrillation Nat Rev Dis Primers. Mar 31;2:16016. 2. Waktare JEP (2002) Atrial Fibrillation. Circulation ; 106:14–16. 3. Rienstra M, Lubitz SA, Mahida S, Magnani JW, Fontes JD et al. (2012) Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. 4. Zoni-Berisso M, Filippi A, Landolina M, Brignoli O, D'Ambrosio G et al. (2013) Frequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from the Italian Survey of Atrial Fibrillation Management [ISAF] study). Am J Cardiol 111 (5): 705-711. 5. Lip GY, Laroche C, Ioachim PM, Rasmussen LH, Vitali-Serdoz L et al. (2014) Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). Eur Heart J 35 (47): 3365-3376. 6. Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI et al. (2015) Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med 128 (5): 509-518 e502. 7. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D et al. (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37 (38): 2893-2962. 8. Cedars-Sinai,https://www.cedars-sinai.org/ ; Naser N 2017)9. Naser N, Dilic M, Durak A, Kulic M, Pepic E et al. (2017) The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation. Mater Sociomed 29 (4): 231-236. 10. Lip GY, Fauchier L, Freedman SB et al. (2016) Atrial Fibrillation Nat Rev Dis Primers. Mar 31;2:16016.

إخلاء مسؤولية: المعلومات الواردة هنا ليست لتقديم النصائح الطبية أو لاستخدامها في التشخيص أو العلاج. نرجو منك التحدث مع طبيبك إن كان لديك أي استفسار.

ME 210440-220421 - KSA 209169-220411